Study Information

Title: A Phase 1 Safety Study of Intradermal ID-LV305 in Patients With Locally Advanced, Relapsed or Metastatic Cancer Expressing NY-ESO-1 External
Status: Recruiting participants
Conditions: Breast Cancer; Melanoma; Non-small Cell Lung Cancer; Ovarian Cancer; Sarcoma
Interventions: Biological: ID-LV305
Institutions: Dana-Farber Cancer Institute
Health Topics: Adenocarcinoma of the Lung, Breast Cancer, Lung Cancer Overview, Melanoma, Ovarian Cancer, Squamous cell carcinoma of the lung

Contact Information


Dana Farber Harvard Cancer Center
Boston, MA 02215
Andrew Wolanski, NP
617-632-2663
Andrew_Wolanski@dfci.harvard.edu